[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @Kapstahoon BioAndTrade BioAndTrade posts on X about $srpt, $imrx, $crwv, $32m the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::823735407460413443/interactions)  - X Week XXXXX -XX% - X Month XXXXXX +339% - X Months XXXXXX +1,770% - X Year XXXXXX +992% ### Mentions: X [#](/creator/twitter::823735407460413443/posts_active)  - X Week XX no change - X Month XX +41% - X Months XX +813% - X Year XX +376% ### Followers: XXX [#](/creator/twitter::823735407460413443/followers)  - X Week XXX +0.53% - X Month XXX +18% - X Months XXX +25% - X Year XXX +6.40% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::823735407460413443/influencer_rank)  ### Social Influence [#](/creator/twitter::823735407460413443/influence) --- **Social category influence** [stocks](/list/stocks) XXXXX% **Social topic influence** [$srpt](/topic/$srpt) #44, [$imrx](/topic/$imrx) 6.9%, [$crwv](/topic/$crwv) 3.45%, [$32m](/topic/$32m) 3.45%, [$arwr](/topic/$arwr) 3.45%, [momentum](/topic/momentum) 3.45%, [events](/topic/events) 3.45%, [$lly](/topic/$lly) 3.45%, [$slno](/topic/$slno) 3.45%, [which i](/topic/which-i) XXXX% **Top accounts mentioned or mentioned by** [@rezfszubagoly](/creator/undefined) [@avidresearch](/creator/undefined) [@scorpionfund](/creator/undefined) [@bioclouseau](/creator/undefined) [@jfais20](/creator/undefined) [@martinperiu11](/creator/undefined) [@trentkelp](/creator/undefined) [@rnaianalyst](/creator/undefined) [@balabioresearch](/creator/undefined) [@semodough](/creator/undefined) [@cholevovo](/creator/undefined) **Top assets mentioned** [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [CoreWeave, Inc. (CRWV)](/topic/$crwv) [Arrowhead Research Corporation (ARWR)](/topic/$arwr) [Eli Lilly and Company (LLY)](/topic/$lly) [Soleno Therapeutics, Inc. Common Stock (SLNO)](/topic/$slno) [Synthetify (SNY)](/topic/$sny) ### Top Social Posts [#](/creator/twitter::823735407460413443/posts) --- Top posts by engagements in the last XX hours "$SRPT presenting lots of data at WMS. safety safety with sarilumab X year follow up efficacy and many more. momentum is also building with price action. so far no new events. Roche dedicated one page in their R&D day. other catalyst Q3 ER $ARWR data non-amb update" [X Link](https://x.com/Kapstahoon/status/1975632546210979962) [@Kapstahoon](/creator/x/Kapstahoon) 2025-10-07T18:41Z XXX followers, 1528 engagements "@rezfszubagoly $SRPT NY medicaid recommends pausing Elevidys. I liked the data which I posted yesterday. It may trigger to other state as well. solid gains from XX so i will wait and see what develops. meanwhile i bought $IMRX and $SLNO" [X Link](https://x.com/Kapstahoon/status/1976020274303861013) [@Kapstahoon](/creator/x/Kapstahoon) 2025-10-08T20:22Z XXX followers, XXX engagements "$SRPT it is late breaker presentation by independent investigator" [X Link](https://x.com/Kapstahoon/status/1975798355210215739) [@Kapstahoon](/creator/x/Kapstahoon) 2025-10-08T05:40Z XXX followers, 1738 engagements "$SRPT i closed all the my positions. I didnt like the news. I was excited after the data. I had bought mig chunk below 11" [X Link](https://x.com/Kapstahoon/status/1975937484241731867) [@Kapstahoon](/creator/x/Kapstahoon) 2025-10-08T14:53Z XXX followers, XXX engagements "$SRPT 3-Year Functional Outcomes of Patients With Duchenne Muscular Dystrophy: Pooled Delandistrogene Moxeparvovec Clinical Trial Data vs External Controls" [X Link](https://x.com/Kapstahoon/status/1975751952890789959) [@Kapstahoon](/creator/x/Kapstahoon) 2025-10-08T02:35Z XXX followers, 2831 engagements "$SRPT WMS 2025 a) no Treatment related SAEs in 3-4 years old (ambulatory).no new safety signals b) micro-dystrophin expression is higher in 3-4 years old compare to =5 years of age" [X Link](https://x.com/Kapstahoon/status/1975742364145885459) [@Kapstahoon](/creator/x/Kapstahoon) 2025-10-08T01:57Z XXX followers, 21.3K engagements "$IMRX used $SRPT proceed to buy more $IMRX . Excellent OS data presented last month. It was $XX AH on sep XX. $SNY buying $25M at XXX. offering announced at XXX but havent closed yet. multiple insiders bought two institutions (Fidelity XXXX% HBM healthcare 5.7%) filed 13G" [X Link](https://x.com/Kapstahoon/status/1975947620645482599) [@Kapstahoon](/creator/x/Kapstahoon) 2025-10-08T15:33Z XXX followers, 1020 engagements "$SRPT good reaction so far overnight tradingkeep in mind that they are also presenting safety when sarilumab used as prophylactic. This is very important data for non-ambulatory patients to reduce ALF. This was one of the key proposal to FDA for non-amb" [X Link](https://x.com/Kapstahoon/status/1975797062500585836) [@Kapstahoon](/creator/x/Kapstahoon) 2025-10-08T05:35Z XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
BioAndTrade posts on X about $srpt, $imrx, $crwv, $32m the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Social category influence stocks XXXXX%
Social topic influence $srpt #44, $imrx 6.9%, $crwv 3.45%, $32m 3.45%, $arwr 3.45%, momentum 3.45%, events 3.45%, $lly 3.45%, $slno 3.45%, which i XXXX%
Top accounts mentioned or mentioned by @rezfszubagoly @avidresearch @scorpionfund @bioclouseau @jfais20 @martinperiu11 @trentkelp @rnaianalyst @balabioresearch @semodough @cholevovo
Top assets mentioned Sarepta Therapeutics, Inc. (SRPT) CoreWeave, Inc. (CRWV) Arrowhead Research Corporation (ARWR) Eli Lilly and Company (LLY) Soleno Therapeutics, Inc. Common Stock (SLNO) Synthetify (SNY)
Top posts by engagements in the last XX hours
"$SRPT presenting lots of data at WMS. safety safety with sarilumab X year follow up efficacy and many more. momentum is also building with price action. so far no new events. Roche dedicated one page in their R&D day. other catalyst Q3 ER $ARWR data non-amb update"
X Link @Kapstahoon 2025-10-07T18:41Z XXX followers, 1528 engagements
"@rezfszubagoly $SRPT NY medicaid recommends pausing Elevidys. I liked the data which I posted yesterday. It may trigger to other state as well. solid gains from XX so i will wait and see what develops. meanwhile i bought $IMRX and $SLNO"
X Link @Kapstahoon 2025-10-08T20:22Z XXX followers, XXX engagements
"$SRPT it is late breaker presentation by independent investigator"
X Link @Kapstahoon 2025-10-08T05:40Z XXX followers, 1738 engagements
"$SRPT i closed all the my positions. I didnt like the news. I was excited after the data. I had bought mig chunk below 11"
X Link @Kapstahoon 2025-10-08T14:53Z XXX followers, XXX engagements
"$SRPT 3-Year Functional Outcomes of Patients With Duchenne Muscular Dystrophy: Pooled Delandistrogene Moxeparvovec Clinical Trial Data vs External Controls"
X Link @Kapstahoon 2025-10-08T02:35Z XXX followers, 2831 engagements
"$SRPT WMS 2025 a) no Treatment related SAEs in 3-4 years old (ambulatory).no new safety signals b) micro-dystrophin expression is higher in 3-4 years old compare to =5 years of age"
X Link @Kapstahoon 2025-10-08T01:57Z XXX followers, 21.3K engagements
"$IMRX used $SRPT proceed to buy more $IMRX . Excellent OS data presented last month. It was $XX AH on sep XX. $SNY buying $25M at XXX. offering announced at XXX but havent closed yet. multiple insiders bought two institutions (Fidelity XXXX% HBM healthcare 5.7%) filed 13G"
X Link @Kapstahoon 2025-10-08T15:33Z XXX followers, 1020 engagements
"$SRPT good reaction so far overnight tradingkeep in mind that they are also presenting safety when sarilumab used as prophylactic. This is very important data for non-ambulatory patients to reduce ALF. This was one of the key proposal to FDA for non-amb"
X Link @Kapstahoon 2025-10-08T05:35Z XXX followers, XXX engagements
/creator/twitter::Kapstahoon